Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 7/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.37 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.37 |
| ▸ | TPI1 | P60174 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL23803149 | 0.95 | LPAR2 (0.40) | LPAR2LPAR1ENPP2LPAR3BTN3A1 | |
| SCHEMBL8847181 | 0.89 | LPAR3 (0.43) | LPAR2LPAR1ENPP2LPAR3CA12 | |
| Trimethylammonium SCHEMBL28961044 | 0.87 | MEN1 (0.37) | LPAR2LPAR1ENPP2LPAR3BTN3A1 | |
| SCHEMBL28707552 | 0.86 | LPAR3 (0.49) | LPAR2LPAR1ENPP2LPAR3CA12 | |
| SCHEMBL3371494 | 0.86 | LPAR3 (0.49) | LPAR2LPAR1ENPP2LPAR3CA12 | |
| SCHEMBL812188 | 0.86 | LPAR3 (0.49) | LPAR2LPAR1ENPP2LPAR3CA12 | |
| Trimethylammonium SCHEMBL28395649 | 0.85 | LPAR3 (0.40) | LPAR2LPAR1ENPP2LPAR3CA12 | |
| SCHEMBL16384827 | 0.84 | LPAR3 (0.39) | LPAR2LPAR1ENPP2LPAR3BTN3A1 | |
| SCHEMBL14678816 | 0.81 | TPI1 (0.36) | LPAR2LPAR1LPAR3BTN3A1TPI1 | |
| SCHEMBL29206160 | 0.81 | ALDH1A1 (0.32) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772245-B | High-robustness self-compacting concrete special-purpose phosphate water reducer and preparation method thereof | 深中通道管理中心 | 2025-05-06 | — | — | CN | claimed |
| CN-115772245-A | High-robustness phosphate water reducing agent special for self-compacting concrete and preparation method thereof | 深中通道管理中心 | 2023-03-10 | — | — | CN | claimed |
| US-8158561-B2 | Scale and corrosion inhibitors for high temperature and pressure conditions | ROHM AND HAAS COMPANY (US) | 2012-04-17 | — | — | US | claimed |
| EP-2298704-A1 | Scale and corrosion inhibitors for high temperature and pressure conditions | Rohm and Haas Company (US) | 2011-03-23 | — | — | EP | claimed |
| US-20110046023-A1 | Scale and corrosion inhibitors for high temperature and pressure conditions | ROHM AND HAAS COMPANY | 2011-02-24 | — | — | US | claimed |
| CN-115772245-B | High-robustness self-compacting concrete special-purpose phosphate water reducer and preparation method thereof | 深中通道管理中心 | 2025-05-06 | — | — | CN | disclosed |
| CN-118139938-A | Chemical mechanical polishing composition with improved particles | 昂士特科技(深圳)有限公司 | 2024-06-04 | — | — | CN | disclosed |
| EP-3848418-B1 | DENTAL CURABLE COMPOSITION AND METHOD FOR PRODUCING DENTAL CURABLE COMPOSITION | TOKUYAMA DENTAL CORP (JP) | 2024-05-22 | — | — | EP | disclosed |
| CN-116254059-B | Chemical mechanical polishing composition for edge polishing | 昂士特科技(深圳)有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-115926629-B | Chemical mechanical polishing composition with improved recycling properties | 昂士特科技(深圳)有限公司 | 2023-12-05 | — | — | CN | disclosed |
| US-11718781-B2 | Method to produce a scale inhibitor | TOUGAS OILFIELD SOLUTIONS GMBH (DE) | 2023-08-08 | — | — | US | disclosed |
| CN-116254059-A | Chemical mechanical polishing composition for edge polishing | 昂士特科技(深圳)有限公司 | 2023-06-13 | — | — | CN | disclosed |
| US-20080266691-A1 | Optical filter, and liquid-crystal display device comprising it | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080266691-A1 | Optical filter, and liquid-crystal display device comprising it | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1716836-A1 | Surface-modified fillers | Ivoclar Vivadent AG (LI) | 2006-11-02 | — | — | EP | disclosed |
| US-20060247329-A1 | Surface-modified fillers | IVOCLAR VIVADENT AG (LI) | 2006-11-02 | — | — | US | disclosed |
| EP-1374829-B1 | Dental material on the basis of acryloester phosphonic acid | IVOCLAR VIVADENT AG (LI) | 2005-11-02 | — | — | EP | disclosed |
| US-6900251-B2 | Dental materials based on acrylic-ester phosphonic acids | IVOCLAR VIVADENT AG (LI) | 2005-05-31 | — | — | US | disclosed |
| US-20040077754-A1 | Dental materials based on acrylic-ester phosphonic acids | IVOCLAR VIVADENT AG (LI) | 2004-04-22 | — | — | US | disclosed |
| EP-1374829-A1 | Dental material on the basis of acryloester phosphonic acid | Ivoclar Vivadent AG (LI) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077754-A1 | Dental materials based on acrylic-ester phosphonic acids | PHOSPHO1, RER1, PTGER1 | LPAR2 1441/4885LPAR1 639/4885ENPP2 911/4885 |
| US-20060247329-A1 | Surface-modified fillers | MSR1, HRH4, OR10J3 | LPAR2 2413/4885LPAR1 1641/4885ENPP2 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.